cnv-2197944
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2013 (NCT01848730)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
Cc1ncccc1C(=O)N1CCN(S(=O)(=O)c2ccc(C(F)(F)F)cc2)C[C@@H]1C- Mol. weight
- 427.45 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314401 ↗
- ChEMBLCHEMBL3545172 ↗
Also known as
- cnv2197944
- cnv2197944
- cnv-2197944
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01893125 | Phase 2 | Aug 1, 2013 | Convergence Pharmaceuticals |
| NCT01848730 | Phase 2 | Apr 1, 2013 | Christiaan Barnard Memorial Hospital, Cape Town, South Africa, Convergence Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Convergence Pharmaceuticals | For profit | 2 | 2 | 1 | 2013 |
| Christiaan Barnard Memorial Hospital, Cape Town, South Africa | Academic/Hospital | 1 | 0 | 1 | 2013 |
2 organizations
Page 1 / 1